Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong. Take 2 mins to learn more.
Market
Cytokinetics, Incorporated
Buy
Sell
One time
AUD
CYTK
≈
0.1063999
CYTK
$50
$150
$500
Pay with
Google Pay
Apple Pay
USD Account
1-2 business days • No fees
Credit/debit card
Instant •
2.99%
0% fee first 30 days
Rank
#13349
All-time high
$126.98
-35.11%
All-time low
$77.09
17.98%
| Time | Price | Change |
|---|---|---|
| Today | 0.00% | |
| 1 day | -$0.89 (0.27%) | |
| 1 week | -$2.43 (1.87%) | |
| 1 month | -$9.72 (8.77%) | |
| 1 year | -$16.06 (14.02%) |
CYTK
$93.985
+0.06%
Cytokinetics is a biopharmaceutical company focused on cancer and cardiovascular disease treatment. Co.'s drug candidate, SB-715992, is a Phase II clinical trials program conducted by its partner GlaxoSmithKline and the National Cancer Institute.
Make investing stress-free
Trade with deep liquidity and low fees
